These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Local application of vancomycin for prophylaxis of graft infection: release of vancomycin from antibiotic-bonded Dacron grafts, toxicity in endothelial cell culture, and efficacy against graft infection in an animal model. Muhl E; Gatermann S; Iven H; Dendorfer A; Bruch HP Ann Vasc Surg; 1996 May; 10(3):244-53. PubMed ID: 8792993 [TBL] [Abstract][Full Text] [Related]
3. Prevention of early vascular graft infection using regional antibiotic release. Kuehn C; Graf K; Mashaqi B; Pichlmaier M; Heuer W; Hilfiker A; Stiesch M; Chaberny IF; Haverich A J Surg Res; 2010 Nov; 164(1):e185-91. PubMed ID: 20828762 [TBL] [Abstract][Full Text] [Related]
4. Does in situ replacement of a staphylococcal infected vascular graft with a rifampicin impregnated gelatin sealed Dacron graft reduce the incidence of subsequent infection? Vicaretti M; Hawthorne W; Ao PY; Fletcher JP Int Angiol; 1999 Sep; 18(3):225-32. PubMed ID: 10688422 [TBL] [Abstract][Full Text] [Related]
5. Prevention of vascular graft infections with antibiotic graft impregnation prior to implantation: in vitro comparison between daptomycin, rifampin and nebacetin. Bisdas T; Beckmann E; Marsch G; Burgwitz K; Wilhelmi M; Kuehn C; Haverich A; Teebken OE Eur J Vasc Endovasc Surg; 2012 Apr; 43(4):448-56. PubMed ID: 22264589 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of quinupristin-dalfopristin in preventing vascular graft infection due to Staphylococcus epidermidis with intermediate resistance to glycopeptides. Giacometti A; Cirioni O; Ghiselli R; Orlando F; Mocchegiani F; Riva A; Del Prete MS; Saba V; Scalise G Antimicrob Agents Chemother; 2002 Sep; 46(9):2885-8. PubMed ID: 12183242 [TBL] [Abstract][Full Text] [Related]
7. Treatment of vascular graft infection by in situ replacement with a rifampin-bonded gelatin-sealed Dacron graft. Goëau-Brissonnière O; Mercier F; Nicolas MH; Bacourt F; Coggia M; Lebrault C; Pechère JC J Vasc Surg; 1994 Apr; 19(4):739-41. PubMed ID: 8164289 [TBL] [Abstract][Full Text] [Related]
8. Linezolid alone and in combination with rifampicin prevents experimental vascular graft infection due to methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis. Sacar M; Sacar S; Kaleli I; Onem G; Turgut H; Goksin I; Ozcan V; Kaan Inan B; Duver H; Baltalarli A J Surg Res; 2007 May; 139(2):170-5. PubMed ID: 17292421 [TBL] [Abstract][Full Text] [Related]
9. Polycationic peptides as prophylactic agents against methicillin-susceptible or methicillin-resistant Staphylococcus epidermidis vascular graft infection. Giacometti A; Cirioni O; Ghiselli R; Goffi L; Mocchegiani F; Riva A; Scalise G; Saba V Antimicrob Agents Chemother; 2000 Dec; 44(12):3306-9. PubMed ID: 11083632 [TBL] [Abstract][Full Text] [Related]
10. A pilot study of a triple antimicrobial-bonded Dacron graft for the prevention of aortic graft infection. Aboshady I; Raad I; Shah AS; Vela D; Dvorak T; Safi HJ; Buja LM; Khalil KG J Vasc Surg; 2012 Sep; 56(3):794-801. PubMed ID: 22579134 [TBL] [Abstract][Full Text] [Related]
11. Prevention of perioperative vascular prosthetic infection with a novel triple antimicrobial-bonded arterial graft. Aboshady I; Raad I; Vela D; Hassan M; Aboshady Y; Safi HJ; Buja LM; Khalil KG J Vasc Surg; 2016 Dec; 64(6):1805-1814. PubMed ID: 26626182 [TBL] [Abstract][Full Text] [Related]
12. Does in situ replacement of a staphylococcal infected vascular graft with a rifampicin impregnated gelatin sealed Dacron graft reduce the incidence of subsequent infection? Vicaretti M; Hawthorne W; Ao PY; Fletcher JP Int Angiol; 2000 Jun; 19(2):158-65. PubMed ID: 10905800 [TBL] [Abstract][Full Text] [Related]
15. Local delivery of vancomycin for the prophylaxis of prosthetic device-related infections. Chilukuri DM; Shah JC Pharm Res; 2005 Apr; 22(4):563-72. PubMed ID: 15846464 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of vancomycin, teicoplanin and fusidic acid as prophylactic agents in prevention of vascular graft infection: an experimental study in rat. Yasim A; Gul M; Atahan E; Ciragil P; Aral M; Ergun Y Eur J Vasc Endovasc Surg; 2006 Mar; 31(3):274-9. PubMed ID: 16360328 [TBL] [Abstract][Full Text] [Related]
17. Prophylaxis against Staphylococcus epidermidis vascular graft infection with rifampicin-soaked, gelatin-sealed Dacron. Sardelic F; Ao PY; Taylor DA; Fletcher JP Cardiovasc Surg; 1996 Jun; 4(3):389-92. PubMed ID: 8782944 [TBL] [Abstract][Full Text] [Related]
18. Microbial pathogenesis of bacterial biofilms: a causative factor of vascular surgical site infection. Frei E; Hodgkiss-Harlow K; Rossi PJ; Edmiston CE; Bandyk DF Vasc Endovascular Surg; 2011 Nov; 45(8):688-96. PubMed ID: 21921082 [TBL] [Abstract][Full Text] [Related]
19. Regional antibiotic delivery for the treatment of experimental prosthetic graft infections. Keeling WB; Myers AR; Stone PA; Heller L; Widen R; Back MR; Johnson BL; Bandyk DF; Shames ML J Surg Res; 2009 Dec; 157(2):223-6. PubMed ID: 19560786 [TBL] [Abstract][Full Text] [Related]
20. Sustained-release vancomycin sheet may help to prevent prosthetic graft methicillin-resistant Staphylococcus aureus infection. Hirose K; Marui A; Arai Y; Nomura T; Inoue S; Kaneda K; Kamitani T; Fujita M; Mitsuyama M; Tabata Y; Komeda M J Vasc Surg; 2006 Aug; 44(2):377-82. PubMed ID: 16890872 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]